Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMears Share News (MER)

Share Price Information for Mears (MER)

Share Price is delayed by 15 minutes
Get Live Data
397.00    2.00 (0.51%)
Bid:
396.50
Ask:
398.50
Spread: 2.00 (0.504%)
Market Cap: £318.21m
MER Live PriceLast checked at - London Stock Exchange

Intraday Mears Share Chart

Mears News

Mears Group flags solid strategic progress
22 Jan 2026

Mears Group flags solid strategic progress

(Sharecast News) - Mears Group said in an update on Thursday that it made significant progress against its strategic objectives in the year ended 31 D...

Mears lifts FY profit oulook, shares jump
8 Dec 2025

Mears lifts FY profit oulook, shares jump

(Sharecast News) - Mears shares shot higher on Monday after it lifted its full-year profit outlook.

TRADING UPDATES: Hercules wins pacts; Mears in strong second half
8 Dec 2025

TRADING UPDATES: Hercules wins pacts; Mears in strong second half

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

SMALL-CAP WINNERS: Mears rises as annual profit set to beat forecasts
8 Dec 2025

SMALL-CAP WINNERS: Mears rises as annual profit set to beat forecasts

(Alliance News) - The following stocks are the leading risers among London Main Market small-caps on Monday.

Berenberg starts coverage of Mears and Capita
29 Oct 2025

Berenberg starts coverage of Mears and Capita

(Sharecast News) - Berenberg initiated coverage of Mears and Capita on Wednesday as it took a look at the UK business services sector.

LONDON BROKER RATINGS: Berenberg says 'buy' Mears and 'hold' Capita
29 Oct 2025

LONDON BROKER RATINGS: Berenberg says 'buy' Mears and 'hold' Capita

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

LONDON BRIEFING: GSK ups 2025 outlook; Next sales beat guidance
29 Oct 2025

LONDON BRIEFING: GSK ups 2025 outlook; Next sales beat guidance

(Alliance News) - GSK raises its outlook for revenue and profit, Next ups its guidance as third quarter sales beat expectations, while Primary Health ...